A novel mutation (Ser951LeufsTer8) in F5 gene leads to hereditary coagulation factor V deficiency

Blood Coagul Fibrinolysis. 2021 Mar 1;32(2):140-145. doi: 10.1097/MBC.0000000000001003.

Abstract

The current study aims to explore the phenotype and genotype of a novel mutation (Ser951LeufsTer8) of F5 gene combined with polymorphism (R485K) in a family of hereditary coagulation factor V deficiency. The factor V activity and antigen were tested with clotting assay and ELISA. The F5 gene was amplified by PCR with direct sequencing and TA-clone-sequenced. The protein structure and harmfulness of the mutation were studied by Swiss-PdbViewer and bioinformatics software. The prothrombin time and activated partial thromboplastin time of proband were significantly prolonged, factor V activity and factor V antigen both were reduced to less than 20%. Sequencing analysis detected proband with Ser951LeufsTer8 and R485K (Arg513Lys), four family members with novel mutation and their factor V activity and factor V antigen were all decreased about 50%. The Ser951LeufsTer8 is associated with decrease in the factor V level of the family, and it is the first mutation report in the position (Ser951LeufsTer8) with factor V deficiency.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Blood Coagulation
  • Factor V / analysis
  • Factor V / genetics*
  • Factor V Deficiency / blood
  • Factor V Deficiency / congenital
  • Factor V Deficiency / genetics*
  • Female
  • Frameshift Mutation
  • Humans
  • Male
  • Mutation
  • Partial Thromboplastin Time
  • Pedigree
  • Polymorphism, Single Nucleotide
  • Prothrombin Time

Substances

  • factor V clotting antigen
  • Factor V